|Institutional Source||Beutler Lab|
|Gene Name||SRY (sex determining region Y)-box 11|
|Synonyms||6230403H02Rik, 1110038H03Rik, end1|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R1265 (G1)|
|Chromosomal Location||27334264-27342574 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 27341736 bp|
|Amino Acid Change||Threonine to Alanine at position 225 (T225A)|
|Ref Sequence||ENSEMBL: ENSMUSP00000078070 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000079063]|
|Predicted Effect||probably benign
AA Change: T225A
PolyPhen 2 Score 0.026 (Sensitivity: 0.95; Specificity: 0.81)
AA Change: T225A
|Meta Mutation Damage Score||0.0898|
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This intronless gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. The protein may function in the developing nervous system and play a role in tumorigenesis. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous null mice display neonatal lethality with impaired ossification and impaired development of the heart, lung, spleen, stomach, skeleton and pancreas. Mice homozygous for a different knock-out allele exhibit abnormal nervous system development and complete neonatal lethality. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Sox11||
(F):5'- TCGAACATGAGGTCGTCTGCATCC -3'
(R):5'- GCACATGGCTGATTATCCCGACTAC -3'
(F):5'- TGCTGCCGCTGGATGAG -3'
(R):5'- TGATTATCCCGACTACAAGTACCG -3'